PFS Partners’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.73K Hold
67
﹤0.01% 464
2026
Q1
$3.5K Hold
67
﹤0.01% 470
2025
Q4
$3.93K Hold
67
﹤0.01% 455
2025
Q3
$3.71K Hold
67
﹤0.01% 450
2025
Q2
$3.43K Hold
67
﹤0.01% 428
2025
Q1
$3.9K Buy
67
+1
+2% +$68 ﹤0.01% 360
2024
Q4
$4.79K Hold
66
﹤0.01% 354
2024
Q3
$5.3K Hold
66
﹤0.01% 345
2024
Q2
$4.75K Hold
66
﹤0.01% 341
2024
Q1
$4.66K Hold
66
﹤0.01% 358
2023
Q4
$5.1K Hold
66
﹤0.01% 339
2023
Q3
$4.5K Hold
66
﹤0.01% 347
2023
Q2
$5.39K Buy
+66
New +$5.3K ﹤0.01% 342

Other funds holding TECH

PFS Partners's TECH Position: Q2 2026 in Review

PFS Partners held its Bio-Techne (TECH) position steady in Q2 2026 at 67 shares worth $4.73K. The position accounts for ﹤0.01% of the portfolio, ranked #464.

PFS Partners first reported a position in TECH in Q2 2023 and has held it in 13 quarters since. The position peaked at $5.39K in Q2 2023. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • PFS Partners held 67 shares of Bio-Techne worth $4.73K as of Q2 2026.
  • PFS Partners left its Bio-Techne share count unchanged in Q2 2026.
  • Bio-Techne made up ﹤0.01% of PFS Partners's portfolio in Q2 2026, its #464 holding.
  • PFS Partners first reported a position in Bio-Techne in Q2 2023 and has held it in 13 quarters since.
  • PFS Partners's Bio-Techne position peaked at $5.39K in Q2 2023.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.